Free Trial

Catalyst Pharmaceuticals (CPRX) Short Interest Ratio & Short Volume

Catalyst Pharmaceuticals logo
$21.12 -0.21 (-0.98%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$21.06 -0.05 (-0.26%)
As of 08/1/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Catalyst Pharmaceuticals Short Interest Data

Catalyst Pharmaceuticals (CPRX) has a short interest of 8.92 million shares. This marks a 9.18% increase in short interest from the previous month. The short interest ratio (days to cover) is 7.4, indicating that it would take 7.4 days of the average trading volume of 1.21 million shares to cover all short positions.

Current Short Interest
8,920,000 shares
Previous Short Interest
8,170,000 shares
Change Vs. Previous Month
+9.18%
Dollar Volume Sold Short
$186.87 million
Short Interest Ratio
7.4 Days to Cover
Last Record Date
July 15, 2025
Outstanding Shares
121,970,000 shares
Percentage of Shares Shorted
7.31%
Today's Trading Volume
999,536 shares
Average Trading Volume
1,210,948 shares
Today's Volume Vs. Average
83%
Short Selling Catalyst Pharmaceuticals?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Catalyst Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CPRX Short Interest Over Time

CPRX Days to Cover Over Time

CPRX Percentage of Float Shorted Over Time

Catalyst Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/15/20258,920,000 shares $186.87 million +9.2%N/A7.4 $20.95
6/30/20258,170,000 shares $177.29 million +5.7%7.5%6.6 $21.70
6/15/20257,730,000 shares $181.89 million +5.2%7.1%6.2 $23.53
5/31/20257,350,000 shares $182.94 million -1.1%6.9%5.8 $24.89
5/15/20257,430,000 shares $176.69 million -7.2%7.0%5.8 $23.78
4/30/20258,010,000 shares $194.56 million +2.8%N/A6.3 $24.29
4/15/20257,790,000 shares $180.96 million -1.8%7.3%6.3 $23.23
3/31/20257,930,000 shares $192.30 million +9.7%7.5%5.6 $24.25
3/15/20257,230,000 shares $151.97 million +16.1%6.8%5.6 $21.02
2/28/20256,230,000 shares $142.60 million +8.9%5.9%5.5 $22.89
2/15/20255,720,000 shares $133.10 million +6.9%5.4%5.3 $23.27
1/31/20255,350,000 shares $120.70 million -19.3%N/A4.7 $22.56
1/15/20256,630,000 shares $152.89 million -0.8%N/A6.1 $23.06
12/31/20246,680,000 shares $139.41 million +12.5%N/A6.9 $20.87
12/15/20245,940,000 shares $127.00 million -2.5%N/A6.6 $21.38
11/30/20246,090,000 shares $134.41 million +7.2%N/A6.4 $22.07
11/15/20245,680,000 shares $117.01 million -5.5%N/A6 $20.60
10/31/20246,010,000 shares $131.02 million +0.8%5.8%6.2 $21.80
10/15/20245,960,000 shares $126.23 million +3.7%5.8%6.1 $21.18
9/30/20245,750,000 shares $114.31 million -2.9%5.6%5.8 $19.88
9/15/20245,920,000 shares $119.70 million +2.6%5.8%5.9 $20.22
8/31/20245,770,000 shares $116.84 million +14.3%5.6%5.3 $20.25
8/15/20245,050,000 shares $100.55 million +4.8%4.9%4.5 $19.91
7/31/20244,820,000 shares $83.10 million -9.9%4.7%4.4 $17.24
7/15/20245,350,000 shares $89.61 million +0.9%5.3%4.6 $16.75
6/30/20245,300,000 shares $82.10 million -22.2%5.2%4.4 $15.49
6/15/20246,810,000 shares $102.56 million -6.3%6.7%5.5 $15.06
5/31/20247,270,000 shares $117.56 million -9.0%7.2%6.2 $16.17
5/15/20247,990,000 shares $133.11 million +3.6%7.9%6.1 $16.66
4/30/20247,710,000 shares $116.04 million +23.0%7.6%5.9 $15.05
4/15/20246,270,000 shares $96.50 million +3.6%6.2%4.7 $15.39
3/31/20246,050,000 shares $96.44 million +3.8%6.1%4.1 $15.94
3/15/20245,830,000 shares $93.69 million -9.9%5.8%3.9 $16.07
2/29/20246,470,000 shares $103.71 million +14.1%6.5%4.3 $16.03
2/15/20245,670,000 shares $78.76 million +20.9%6.2%4.1 $13.89
1/31/20244,690,000 shares $67.54 million -21.3%5.1%3.3 $14.40
1/15/20245,960,000 shares $86.36 million +5.9%6.5%4 $14.49
12/31/20235,630,000 shares $94.64 million -21.6%6.1%4 $16.81
12/15/20237,180,000 shares $103.25 million +4.7%7.9%5.8 $14.38
11/30/20236,860,000 shares $98.99 million +3.0%7.5%5.7 $14.43
China just unlocked Nvidia’s AI chips—what that means for you (Ad)

Tired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system tracks breaking AI news and shows when to trade.📈 AI-backed. Beginner-friendly. Results proven.

11/15/20236,660,000 shares $90.91 million +3.7%7.3%5.5 $13.65
10/31/20236,420,000 shares $79.67 million +2.4%7.0%5.2 $12.41
10/15/20236,270,000 shares $80.13 million -1.3%6.8%5.2 $12.78
9/30/20236,350,000 shares $74.23 million -20.0%6.9%5.2 $11.69
9/15/20237,940,000 shares $98.93 million +10.9%8.7%6.2 $12.46
8/31/20237,160,000 shares $100.53 million +6.1%7.2%4.7 $14.04
8/15/20236,750,000 shares $101.12 million +2.4%6.8%4.2 $14.98
7/31/20236,590,000 shares $91.14 million -8.3%6.6%3.5 $13.83
7/15/20237,190,000 shares $92.46 million -9.1%7.2%3.7 $12.86
6/30/20237,910,000 shares $106.31 million -6.2%8.0%4 $13.44
6/15/20238,430,000 shares $104.28 million -8.0%8.5%4.3 $12.37
5/31/20239,160,000 shares $105.80 million -3.5%9.2%4.7 $11.55
5/15/20239,490,000 shares $124.70 million -15.2%9.6%4.9 $13.14
4/30/202311,190,000 shares $178.14 million +2.2%11.2%6.5 $15.92
4/15/202310,950,000 shares $193.71 million -3.4%11.0%5 $17.69
3/31/202311,330,000 shares $187.85 million +15.9%11.4%5 $16.58
3/15/20239,780,000 shares $140.25 million -5.7%9.9%4.1 $14.34
2/28/202310,370,000 shares $158.25 million +6.5%10.6%4.4 $15.26
2/15/20239,740,000 shares $149.61 million +12.9%10.0%3.8 $15.36
1/31/20238,630,000 shares $133.68 million -15.3%8.8%3.1 $15.49
1/15/202310,190,000 shares $214.50 million -3.0%10.4%3.9 $21.05
12/30/202210,510,000 shares $195.49 million +38.8%10.8%4.7 $18.60
12/15/20227,570,000 shares $127.48 million -4.2%7.7%3.2 $16.84
11/30/20227,900,000 shares $132.48 million +18.4%8.1%2.5 $16.77
11/15/20226,670,000 shares $105.99 million -17.3%6.8%2 $15.89
10/31/20228,060,000 shares $111.79 million -7.6%8.4%2.5 $13.87
10/15/20228,720,000 shares $109.44 million -3.8%9.0%2.7 $12.55
9/30/20229,060,000 shares $116.24 million +82.3%9.4%2.7 $12.83
9/15/20224,970,000 shares $67.69 million -20.1%5.2%1.5 $13.62
8/31/20226,220,000 shares $84.22 million -8.4%6.6%2.9 $13.54
8/15/20226,790,000 shares $96.62 million -3.7%7.2%3.7 $14.23
7/31/20227,050,000 shares $72.19 million -20.3%7.4%4.5 $10.24
7/15/20228,840,000 shares $75.76 million -13.3%9.3%6.2 $8.57
6/30/202210,190,000 shares $71.43 million +4.3%10.7%8.8 $7.01
6/15/20229,770,000 shares $63.60 million +11.0%10.3%8.4 $6.51
5/31/20228,800,000 shares $63.36 million +18.1%9.3%7.8 $7.20
5/15/20227,450,000 shares $51.48 million +45.8%7.8%6.4 $6.91
4/30/20225,110,000 shares $38.94 million +10.6%5.4%4.3 $7.62
4/15/20224,620,000 shares $38.85 million +1.1%4.9%4 $8.41
3/31/20224,570,000 shares $37.89 million -3.8%4.8%3.9 $8.29
3/15/20224,750,000 shares $35.82 million -9.7%5.0%4.2 $7.54
2/28/20225,260,000 shares $41.03 million +2.7%5.5%4.6 $7.80
2/15/20225,120,000 shares $39.53 million +18.2%5.4%4.6 $7.72
1/31/20224,330,000 shares $24.94 million +13.7%4.5%4 $5.76
1/15/20223,810,000 shares $23.77 million +6.1%N/A3.9 $6.24
12/31/20213,590,000 shares $24.30 million -15.1%3.8%3.9 $6.77
12/15/20214,230,000 shares $29.27 million +3.9%4.4%4.1 $6.92
11/30/20214,070,000 shares $28.49 million -2.4%4.3%4.6 $7.00
11/15/20214,170,000 shares $30.44 million -2.1%4.4%4.7 $7.30
10/29/20214,260,000 shares $25.13 million -3.4%4.5%5.1 $5.90
China just unlocked Nvidia’s AI chips—what that means for you (Ad)

Tired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system tracks breaking AI news and shows when to trade.📈 AI-backed. Beginner-friendly. Results proven.

10/15/20214,410,000 shares $26.59 million -7.0%4.6%5.3 $6.03
9/30/20214,740,000 shares $25.12 million -9.2%5.0%5.5 $5.30
9/15/20215,220,000 shares $26.10 million -0.8%5.5%6.1 $5.00
8/31/20215,260,000 shares $28.98 million -7.4%5.5%5.5 $5.51
8/13/20215,680,000 shares $34.31 million -2.1%5.9%5.7 $6.04
7/30/20215,800,000 shares $33.87 million +1.9%6.0%5.2 $5.84
7/15/20215,690,000 shares $31.41 million -11.8%5.9%4.8 $5.52
6/30/20216,450,000 shares $37.09 million -30.2%6.7%5.2 $5.75
6/15/20219,240,000 shares $52.48 million -3.8%9.6%7.5 $5.68
5/28/20219,600,000 shares $53.09 million -9.9%10.0%7.1 $5.53
5/14/202110,660,000 shares $53.09 million -2.0%11.1%7.3 $4.98
4/30/202110,880,000 shares $51.68 million -7.1%11.3%7.2 $4.75
4/15/202111,710,000 shares $52.23 million -5.3%12.1%7 $4.46
3/31/202112,370,000 shares $53.69 million +29.5%12.8%7 $4.34
3/15/20219,550,000 shares $37.15 million +13.7%9.9%4.9 $3.89
2/26/20218,400,000 shares $32.76 million -8.8%8.7%4.5 $3.90
2/12/20219,210,000 shares $39.83 million -6.6%9.6%4.9 $4.33
1/29/20219,860,000 shares $35.50 million -2.7%10.2%5.3 $3.60
1/15/202110,130,000 shares $35.76 million -0.3%10.5%6 $3.53
12/31/202010,160,000 shares $34.75 million -17.3%10.5%6.3 $3.42
12/15/202012,280,000 shares $47.03 million -4.2%12.7%7.4 $3.83
11/30/202012,820,000 shares $47.43 million -4.6%13.3%8.4 $3.70
11/15/202013,440,000 shares $45.70 million +0.1%13.9%8.8 $3.40
10/30/202013,430,000 shares $41.77 million +4.9%13.9%7.9 $3.11
10/15/202012,800,000 shares $40.83 million -6.2%13.3%6.6 $3.19
9/30/202013,640,000 shares $40.51 million +17.2%14.2%6.9 $2.97
9/15/202011,640,000 shares $39.11 million -7.4%12.1%6.2 $3.36
8/31/202012,570,000 shares $41.23 million +2.0%13.1%6.3 $3.28
8/14/202012,330,000 shares $42.79 million +7.0%12.8%6.1 $3.47

CPRX Short Interest - Frequently Asked Questions

What is Catalyst Pharmaceuticals' current short interest?

Short interest is the volume of Catalyst Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of July 15th, traders have sold 8,920,000 shares of CPRX short. Learn More on Catalyst Pharmaceuticals' current short interest.

What is a good short interest ratio for Catalyst Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CPRX shares currently have a short interest ratio of 7.0. Learn More on Catalyst Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Catalyst Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Catalyst Pharmaceuticals: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Catalyst Pharmaceuticals' short interest increasing or decreasing?

Catalyst Pharmaceuticals saw a increase in short interest in July. As of July 15th, there was short interest totaling 8,920,000 shares, an increase of 9.2% from the previous total of 8,170,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Catalyst Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Catalyst Pharmaceuticals: Verona Pharma PLC American Depositary Share (4.77%), BridgeBio Pharma, Inc. (10.26%), Blueprint Medicines Corporation (5.95%), Roivant Sciences Ltd. (10.56%), Legend Biotech Corporation Sponsored ADR (4.57%), Elanco Animal Health Incorporated (4.75%), Regencell Bioscience Holdings Limited (9.57%), Revolution Medicines, Inc. (7.33%), Grifols, S.A. (0.96%), TG Therapeutics, Inc. (15.22%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Coinbase Global, Inc. ($5.11 billion), Charter Communications, Inc. ($4.76 billion), Reddit Inc. ($2.84 billion), SoFi Technologies, Inc. ($2.79 billion), Seagate Technology Holdings PLC ($2.79 billion), Live Nation Entertainment, Inc. ($2.67 billion), Rocket Lab Corporation ($2.49 billion), AST SpaceMobile, Inc. ($2.12 billion), Moderna, Inc. ($2.09 billion), and Omnicom Group Inc. ($2.04 billion). View all of the most shorted stocks.

What does it mean to sell short Catalyst Pharmaceuticals stock?

Short selling CPRX is an investing strategy that aims to generate trading profit from Catalyst Pharmaceuticals as its price is falling. CPRX shares are trading down $0.21 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Catalyst Pharmaceuticals?

A short squeeze for Catalyst Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of CPRX, which in turn drives the price of the stock up even further.

How often is Catalyst Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CPRX, twice per month. The most recent reporting period available is July, 15 2025.




This page (NASDAQ:CPRX) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners